Cutler Group LLC / CA - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 188 filers reported holding DENALI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$15
-81.2%
1,700
-77.8%
0.00%
-85.7%
Q4 2022$80
-99.8%
7,650
+23.4%
0.01%
+133.3%
Q3 2022$47,000
+135.0%
6,200
+811.8%
0.00%
+200.0%
Q2 2022$20,000
-52.4%
680
-66.0%
0.00%
-50.0%
Q1 2022$42,000
-44.0%
2,000
-9.1%
0.00%
-33.3%
Q4 2021$75,000
+17.2%
2,200
-50.7%
0.00%0.0%
Q3 2021$64,000
+60.0%
4,460
+85.8%
0.00%
+50.0%
Q2 2021$40,000
+5.3%
2,400
+26.3%
0.00%0.0%
Q1 2021$38,000
-78.9%
1,900
-71.2%
0.00%
-77.8%
Q4 2020$180,000
+1900.0%
6,600
+214.3%
0.01%
+800.0%
Q3 2020$9,000
-73.5%
2,100
+45.8%
0.00%
-50.0%
Q2 2020$34,000
+6.2%
1,440
-44.6%
0.00%
+100.0%
Q1 2020$32,000
+300.0%
2,600
+420.0%
0.00%
Q4 2019$8,000
+700.0%
500
+400.0%
0.00%
Q3 2019$1,000
-50.0%
1000.0%0.00%
Q2 2019$2,0000.0%1000.0%0.00%
Q4 2018$2,0001000.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$339,037,00035.95%
Euclidean Capital LLC 323,749$27,117,0005.74%
Flagship Pioneering Inc. 2,730,263$228,687,0004.16%
Casdin Capital, LLC 1,310,000$109,726,0003.25%
A.R.T. Advisors, LLC 6,173$517,0002.39%
MARK ASSET MANAGEMENT LP 172,040$14,410,0001.73%
Temasek Holdings (Private) Ltd 4,410,457$369,420,0001.59%
Integral Health Asset Management, LLC 57,500$4,816,0001.43%
GILDER GAGNON HOWE & CO LLC 3,219,843$269,694,0001.34%
IRONWOOD INVESTMENT MANAGEMENT LLC 19,365$1,622,0000.95%
View complete list of DENALI THERAPEUTICS INC shareholders